AG-100

N/A

Report date: 2026/03/17 13:38:44
NME

Base Information

Drug NameAG-100
Drug Alias NameTGF-beta related responses inhibitor (Allgenesis Biotherapeutics)AG-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOcular fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAllgenesis Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOcular fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A